Researchers led by Virginia Tech have found that inhibiting proteins ID1 and ID3 can halt and even reverse lung scarring in pre-clinical models of idiopathic pulmonary fibrosis. The approach improved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results